CDIO Stock Chart & Stats
$2.01
-$0.13(-15.46%)
At close: 4:00 PM EST
$2.01
-$0.13(-15.46%)
Day’s Range― - ―
52-Week Range$0.97 - $7.91
Previous Close$0.73
Volume1.61M
Average Volume (3M)37.14K
Market Cap
$5.89M
Enterprise Value-$2.44M
Total Cash (Recent Filing)$7.08M
Total Debt (Recent Filing)$533.00K
Price to Earnings (P/E)―
Beta2.57
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.38
Shares Outstanding2,959,469
10 Day Avg. Volume36,827
30 Day Avg. Volume37,139
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.68
Price to Sales (P/S)320.16
P/FCF Ratio-0.80
Enterprise Value/Market Cap-0.42
Enterprise Value/Revenue-147.55
Enterprise Value/Gross Profit31.30
Enterprise Value/Ebitda0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-16.5
Revenue Forecast (FY)$25.00M
Cardio Diagnostics Holdings News
CDIO FAQ
What was Cardio Diagnostics Holdings’s price range in the past 12 months?
Cardio Diagnostics Holdings lowest stock price was $0.97 and its highest was $7.91 in the past 12 months.
What is Cardio Diagnostics Holdings’s market cap?
Cardio Diagnostics Holdings’s market cap is $5.89M.
When is Cardio Diagnostics Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cardio Diagnostics Holdings’s earnings last quarter?
Currently, no data Available
Is Cardio Diagnostics Holdings overvalued?
According to Wall Street analysts Cardio Diagnostics Holdings’s price is currently Overvalued.
Does Cardio Diagnostics Holdings pay dividends?
Cardio Diagnostics Holdings does not currently pay dividends.
What is Cardio Diagnostics Holdings’s EPS estimate?
Cardio Diagnostics Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cardio Diagnostics Holdings have?
Cardio Diagnostics Holdings has 2,959,469 shares outstanding.
What happened to Cardio Diagnostics Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cardio Diagnostics Holdings?
Currently, no hedge funds are holding shares in CDIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cardio Diagnostics Holdings
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Technical Analysis
Theriva Biologics
―
Galmed Pharmaceuticals
―
―
Cyclerion Therapeutics
―
Silexion Therapeutics
―
Ownership Overview
2.72%
Insiders
1.39% Mutual Funds
0.47% Other Institutional Investors
94.74% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---